Kennedy Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-33,853
Closed -$2.42M 754
2023
Q4
$2.42M Sell
33,853
-1,846
-5% -$132K 0.05% 452
2023
Q3
$2.14M Buy
35,699
+1,215
+4% +$72.8K 0.05% 447
2023
Q2
$2.49M Buy
34,484
+19,815
+135% +$1.43M 0.06% 419
2023
Q1
$1.08M Buy
14,669
+3,422
+30% +$252K 0.03% 478
2022
Q4
$751K Sell
11,247
-6,803
-38% -$454K 0.02% 518
2022
Q3
$970K Buy
18,050
+2
+0% +$107 0.03% 485
2022
Q2
$1.01M Buy
18,048
+880
+5% +$49K 0.03% 473
2022
Q1
$1.21M Sell
17,168
-168
-1% -$11.8K 0.03% 479
2021
Q4
$1.67M Sell
17,336
-605
-3% -$58.3K 0.04% 468
2021
Q3
$1.56M Sell
17,941
-1,074
-6% -$93.3K 0.03% 486
2021
Q2
$1.56M Sell
19,015
-4,945
-21% -$405K 0.03% 499
2021
Q1
$2.28M Sell
23,960
-152,517
-86% -$14.5M 0.05% 503
2020
Q4
$10.9M Buy
176,477
+85,431
+94% +$5.3M 0.25% 126
2020
Q3
$5.41M Sell
91,046
-158,313
-63% -$9.41M 0.16% 244
2020
Q2
$17.4M Sell
249,359
-11,659
-4% -$814K 0.5% 19
2020
Q1
$11.8M Buy
261,018
+148,625
+132% +$6.74M 0.44% 22
2019
Q4
$7.31M Buy
112,393
+20,578
+22% +$1.34M 0.18% 199
2019
Q3
$5.7M Buy
91,815
+65,795
+253% +$4.09M 0.14% 275
2019
Q2
$1.85M Sell
26,020
-48,164
-65% -$3.43M 0.04% 547
2019
Q1
$5.82M Buy
74,184
+55,875
+305% +$4.38M 0.14% 282
2018
Q4
$1.55M Sell
18,309
-57,798
-76% -$4.89M 0.04% 564
2018
Q3
$13M Buy
76,107
+1,468
+2% +$251K 0.24% 111
2018
Q2
$9.65M Buy
74,639
+1,638
+2% +$212K 0.18% 174
2018
Q1
$7.52M Sell
73,001
-1,290
-2% -$133K 0.15% 244
2017
Q4
$6.35M Sell
74,291
-341
-0.5% -$29.1K 0.11% 329
2017
Q3
$6.34M Buy
+74,632
New +$6.34M 0.11% 317